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Abstract 
A IDS is a devastating disease that affects 28,000 people in the 
United States and has claimed over 16,000 lives. More than 270,000 
persons are expected to contract the syndrome by 1991. Most AIDS 
patients are male homosexuals, intravenous drug users, of Haitian descent, 
or hemophiliacs. The causative agent in AIDS is the retrovirus 
HTLV-111/LAV. Infection with the AIDS virus causes a major collapse of 
the T-cell arm of the immune system, rendering the host vulnerable to a 
multitude of opportunistic infections and neoplasms. 
The most common fundus change observed in AIDS is cotton-wool 
spots . Cytomegalovirus (CMV) retinitis is the most damaging ocular 
finding since it may lead to total retinal atrophy. Retinal hemorrhages, 
Roth spots, and periphlebitis are manifestations of microvascular 
alterations that occur in AIDS. Opportunistic infections by Toxoplasma sp. 
and Mycobacterium sp. may also be manifest. 
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INTRODUCTION 
No epidemic in modern history has gained the notoriety of the 
acquired immunodeficiency syndrome (AIDS). Since its recognition as a 
public health problem in 1980, AIDS has claimed over 16,000 lives. As of 
December 8, 1986, over 28,000 cases of AIDS had been documented by the 
Center for Disease Control (CDC). 1 This figure represents a marked 
contrast to the 110 AIDS cases that had been reported by September of 
1981. The AIDS crisis is expected to deepen in the future. Experts project 
that there will be nearly 270,000 cases of AIDS in the United States by 
1991.2 
Ninety-three percent of those infected with the AIDS virus are men. 
However, an increasing number of women and children are contracting the 
disease. 1 Most reported cases of the syndrome fall into four major risk 
groups. These groups include male homosexuals, intravenous drug users, 
persons of Haitian origin, and persons dependent upon donated blood 
products. 3 The majority of AIDS cases afflict homosexual or bisexual 
males. 
The retrovirus that is believed to be the causative agent in acquired 
immunodeficiency syndrome was first isolated by F. Barre-Sinoussi and 
coworkers at the Pasteur Institute in 1983.4 The French team labeled 
their isolate lymphadenopathy virus (LAV). 
Shortly after the LAV isolation, Gallo and a group of researchers at 
the Cancer Institute reported the isolation of a similar virus which they 
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called human T-cell lymphotropic virus type Ill (HTLV-111).5 It appears 
that LAV and HTLV-111 represent the same virus. The transmission of 
either of the two viruses may cause AIDS. 
Three modes of transmission are responsible for the vast majority of 
HTLV-111/LAV infections.6 Exposure to infected semen during sexual 
contact accounts for most AIDS virus infections. Transmission of the 
virus also occurs via intravenous injections using contaminated needles. 
The administration of blood products can cause AIDS, especially factor 
VIII preparations for hemophiliacs. 6 Experts agree that the transmission 
of HTLV-111/LAV seems to be similar to that of the hepatitis B virus? 
The major clinical finding in a patient infected with AIDS is collapse 
of the body's immune system. A severe dysfunction of the T -cell arm of 
the system has been found to occur.8 This dysfunction includes a decrease 
in the number of T-helper cells and a relative increase in the number of 
circulating T-suppressor cells. Humoral immune function appears to be 
intact in AIDS.8 
Since the immune system is compromised, the AIDS patient is 
vulnerable to a host of opportunistic infections and neoplasms that are 
normally prevented. Systemic manifestations of AIDS include infections 
by Pneumocystis carinii, Cytomegalovirus(CMV), Herpes simplex, hepatitis 
B, Mycobacterium tuberculosis, Klebsiella pneumoniae, Candida albicans, 
Cryptococcus neotormans, and toxoplasmosis.9 The most common of these 
systemic afflictions is Pneumocystis carinii pneumonia, which affects 51 
percent of AIDS patients.3 
In addition to the multitude of systemic complications, 75 to 90 
percent of AIDS patients have ocular signs attributable to the 
syndrome.10,11 The AIDS virus has been isolated from nearly all ocular 
fluids and tissues. Fujikawa and coworkers reported the isolation of 
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HTLV-111 from the tears of an AIDS patient. 12 Fujikawa has also noted the 
culture of the virus from the vitreous of one patient with the syndrome. 
Other teams of researchers have isolated the AIDS virus from the cornea 
and conjunctiva of patients with AIDS.13• 14 Recently, Tervo reported the 
recovery of HTLV-111 from contact lenses that had been worn overnight by 
an AIDS patient. 15 The isolation of the virus from these media is 
indicative of the syndrome's affinity for the eye. 
Ocular manifestations of AIDS include fundus changes, anterior 
segment opportunistic infections, neoplasms, and central nervous system 
involvement. Anterior segment infections include herpes simplex and 
herpes zoster. Conjunctival Kaposi's sarcoma is a common vascular lesion 
affecting AI OS patients. Central nervous system fungal infections may 
cause extraocular muscle paresis. The frequency of these ophthalmic 
manifestations indicates that many patients with AIDS will seek 
treatment from an eye doctor. Thus, the optometrist should be aware of 
the ocular conditions associated with the syndrome. This paper will focus 
on the fundus changes associated with the acquired immunodeficiency 
syndrome. 
FUNDUS CHANGES 
Cotton-wool spots. The most common ophthalmoscopic finding in 
AIDS is cotton-wool spots (see Figure 1 ). Between 25 and 92 percent of 
persons with the syndrome present with these white opacities.1 7 • 1 8 
Retinal cotton-wool lesions associated with AIDS have an affinity for the 
posterior pole around the optic nerve head and vascular arcades.9• 11 
The precise etiology of cotton-wool spots in Al DS remains unclear.19 
The spots appear to be identical to those found in a number of systemic 
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Figure 1. Cotton-wool spots. 
diseases including diabetes mellitus, hypertension, leukemia, and 
anemia. 17 Therefore, the presence of these conditions must be ruled out. 
McLeod describes the morphology of cotton-wool spots as the 
accumulation of cytoplasmic organelles in nerve fiber layer axons 
resulting from obstruction of axoplasmic transport. 20 This obstruction 
seems to occur at the border areas of retinal ischemia. Thus, the presence 
of cotton-wool spots seems to indicate a microvascular alteration in 
AIDS. 10 
Kwok postulates that the cotton-wool patches in AIDS occur as a 
direct result of Pneumocystis carinii infection of the retina. 21 Holland 
suggests that the lesions might result from a focal immune-complex 
vasculitis secondary to chronic cytomegalovirus infection.22 However, 
neither of these postulates have been substantiated greatly in the 
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literature. 
The appearance of cotton-wool patches in AIDS is often followed by 
spontaneous disappearance. In a prospective study, Freeman and 
associates reported that the appearance and disappearance of cotton-wool 
spots did not seem to be related to the general medical status of AIDS 
patients. 23 Cotton-wool spots were observed to appear in some patients 
as their clinical status improved and others when it deteriorated. This 
transient nature of cotton-wool patches serves as an important 
differential diagnostic factor. Cotton-wool lesions may be distinguished 
from early cytomegalovirus retinitis, another common retinal 
manifestation of AIDS, by lack of enlargement during serial observation .1 0 
Cytomegalovirus (CMV) retinitis. The major cause of visual loss 
in AIDS is CMV retinitis. 1° CMV retinitis is often preceded by 
cotton-wool lesions, but a recent study suggests that CMV infection plays 
no role in the production of cotton-wool spots in AIDS.24 
CMV retinitis results from an opportunistic infection that affects all 
layers of the retina. Early lesions of CMV appear as areas of dry, white, 
granular retinal opacifications adjacent to the major retinal vessels. 1 6 
Initially, these manifestations may resemble cotton-wool spots, but are 
more grainy and dense in appearance and lie deeper than cotton-wool 
spots.18,23 The lesions do not disappear spontaneously but may undergo 
periods of remission. 
The early granular lesions eventually coalesce and spread. 
Histologically, these retinal lesions are characterized by coagulative 
necrosis of the retina.22 Large cells containing inclusion bodies are found 
in the retinal layers. Retinal hemorrhage accompanies the necrosis and 
gives the disease its characteristic "brushfire" appearance. 25 The 
end-stage of CMV retinitis is total retinal atrophy. Once the retina is 
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totally atrophic, no CMV inclusions are demonstrable by electron 
microscopy .1 0 
In addition to cotton-wool spots, differential diagnosis of CMV 
retinitis includes toxoplasmosis retinitis, acute retinal necrosis, and 
syphilis. 11 Toxoplasmosis usually occurs with a vitritis. Acute retinal 
necrosis is of sudden onset. Syphilis can mimic several neuroretinal 
diseases. 
The accuracy of the diagnosis of CMV retinitis may be increased by 
the isolation of cytomegalovirus from the blood, urine, or eye.26 However, 
active CMV retinitis cannot be excluded because of the absence of 
serologic or microbiologic evidence of CMV. Neuwirth described the 
diagnosis of CMV retinitis though he could not isolate the virus 
serologically or culture it from other organs.27 
Treatment of cytomegalovirus retinitis has been frustrating. 
Conventional antiviral agents such as vidarabine and acyclovir have proven 
ineffective. 11 Recently, there have been encouraging reports concerning 
the effectiveness of other antiviral agents. Palestine noted 
chemotherapeutic success with dihydroxy propoxymethyl guanine.26 In the 
study, CMV retinitis clinically responded to chemotherapy in 12 of 14 
affected eyes. Palestine emphasizes that the agent merely suppresses but 
does not eliminate the virus. 
The prognosis is very poor for the AIDS patient with CMV retinitis . 
One study reported that death occurred six weeks after the diagnosis of 
the condition. 8 Other authors cited mortality at four months after the 
diagnosis of CMV retinitis. 18 Hence, the "brushfire" appearance is of great 
concern when monitoring the AIDS patient. 
Retinal hemorrhages. Another common ophthalmoscopic 
observation in AIDS is retinal hemorrhage. Up to 92 percent of AIDS 
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patients present with these vascular lesions. 18 The majority of 
hemorrhages found in AIDS are flame-shaped hemorrhages of the nerve 
fiber layer.18,28 Deeper blot-type hemorrhages have also been observed 
in AI OS patients .18 These hemorrhages may be isolated, or occur with 
cotton-wool spots. Like cotton-wool spots, hemorrhages often resolve 
spontaneously, and are not indicative of the patients' clinical status.16,23 
When hemorrhages are observed in a suspected AIDS case, other 
systemic conditions known to cause retinal hemorrhage must be ruled out. 
These conditions include hypertension, collagen vascular disease, renal 
failure, and diabetes. 
Fluorescein-angiographic study has demonstrated microvascular 
abnormalities in AIDS that are similar to the changes found in diabetes 
mellitus.1 8 Microaneurysms, telangiectasias, focal areas of nonperfusion, 
and capillary loss have been documented in the retinas of AIDS patients. 
In one angiographic study, microvascular retinopathy was observed in all 
patients examined.18 
Roth spots. Retinal hemorrhages in AIDS often have white central 
areas called Roth spots. In addition to AIDS, Roth spots occur with 
bacterial endocarditis, leukemia, anoxia, and anemia.29 
Until recently, it was largely agreed that Roth spots represented a 
central accumulation of leukocytes in the hemorrhage. Contemporary 
literature suggests that these white central opacifications represent a 
fibrin thrombus.29 When a patient presents with retinal hemorrhages and 
Roth spots, there may be few, if any, ocular symptoms.16 
Periphlebitis. An additional vascular anomaly that has been 
described in AIDS is retinal periphlebitis . 8·30 This perivasculitis is 
characterized by dense white sheathing of the branches of the central 
retinal vein. Vessel sheathing extends to the peripheral retina and may 
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affect some retinal arterioles. 
Retinal periphlebitis in AIDS is believed to be part of the 
noninfectious retinopathy of the syndrome.3° Careful examinations of the 
peripheral retina in patients with AIDS could identify subtle perivascular 
sheathing as an early ocular finding. 
Toxoplasmosis. Although profuse systemic toxoplasmosis is 
common in AIDS, ocular infection by Toxoplasma gondii is rare.31 ,32 The 
pathogenesis of ocular toxoplasmosis in AIDS is different than that of 
typical ocular toxoplasmosis.32 
Ocular toxoplasmosis typically presents as a focal necrotizing 
retinochoroiditis. The presentation of toxoplasmosis in AIDS is diffuse 
and resembles acute retinal necrosis. The presence of vitritis with ocular 
toxoplasmosis differentiates this condition from acute retinal necrosis. 
Choroidal granulomas. Noncaseating granulomatous inflammation 
of the choroid has been described in AIDS.8·24 These granulomas 
consisted of macrophages with intracellular acid-fast bacilli consistent 
with Mycobacterium avium intracellulare. 
Nonreactive Mycobacterium tuberculosis has also been described in 
AI OS. 33 Croxatto and coworkers noted the presence of miliary tubercles 
in the choroid of a homosexual with AIDS. 
SUMMARY 
Since early visual symptoms may be absent in AIDS, it is the role of 
the optometrist to recognize initial ocular signs of the disease. In 
addition to the fundus changes described, recognition of anterior segment 
manifestations of AIDS in young persons should alert the doctor. A 
thorough case history is essential when a patient presents with ocular 
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findings indicative of AIDS. Proper diagnosis is also necessary to avoid 
inappropriate corticosteroid therapy of opportunistic infections. 
In March of 1987, the FDA approved the antiviral drug azidothymidine 
(AZT) for the treatment of AIDS patients. Successful clinical trials 
demonstrated the drug's ability to prolong the lives of patients with the 
syndrome. Consequently, the prevalence of ocular AIDS is expected to 
increase. Hence, the eye doctor should be aware of the ocular changes that 
are manifest in the disease. 
9 
REFERENCES 
1. CDC: Update: Acquired immunodeficiency syndrome - United States. 
MMWR 12 Dec 1986; 35(49):757-766. 
2. Morgan WM, et al: Acquired immunodeficiency syndrome: current and 
future trends. Public Health Rep Sep-Oct 1986; 101 (5)458-466. 
3. CDC: Update on acquired immune deficiency syndrome (AIDS) - United 
States. MMWR 24 Sep 1982; 31 (37):507-514. 
4. Barre-Sinoussi F, et al: Isolation of a T-lymphotrophic retrovirus 
from a patient at risk for acquired immunodeficiency syndrome 
(AIDS). Science 20 May 1983; 220(4599) :868-871. 
5. Gallo RC, et at: Frequent detection and isolation of cytopathic 
retroviruses (HTLV-111) from patients with AIDS and at risk for AIDS. 
Science 4 May 1984; 220(4648):500-503. 
6. Chandler JW: AIDS and the practice of ophthalmology. The CLOA J Apr 
1986; 12(2) :70. 
7. Jacobs RJ: Infection control guidelines for optometrists and contact 
lens practitioners. Clin Exp Opt Mar 1986; 69(2) :40-45. 
8. Holland GN, et al: Acquired immune deficiency syndrome - ocular 
manifestations. Ophthalmol Aug 1983; 90(8) :859-873. 
9. Bass SJ: Ocular manifestations of AIDS. JAOA Oct 1984; 
55(1 0):765-769 . 
10. Palestine AG, et al: 
immunodeficiency syndrome. 
Ophthalmic involvement in acquired 
Ophthalmol Sep 1984; 91 (9):1 092-1099. 
11. Den Beste BP, et al: AIDS: a review and guide for infection control. 
JAOA Sep 1986; 57(9):675-682. 
12. Fujikawa LS, et al: Isolation of human T-lymphotropic virus type Ill 
from the tears of a patient with the acquired immunodeficiency 
syndrome. The Lancet 7 Sep 1985; 2(8454):529. 
10 
13. Salahuddin SZ, et al: Isolation of the human T-cell 
leukemia/lymphotropic virus type Ill from the cornea. 
Ophthalmol Feb 1986; 101 (2):149-152. 
Am J 
14. Doro S, et al: Confirmation of HTLV-111 virus in cornea. Am J 
Ophthalmol Sep 1986; 1 02(3):390. 
15. Tervo T, et al: Recovery of HTLV-111 from contact lenses. The Lancet 
15 Feb 1986; 1 (8477):379-380. 
16. Jacobs RJ: Acquired immune deficiency syndrome and the optometrist. 
Clin Exp Opt Mar 1986; 69(2):46-52. 
17. Khadem M, et al: Ophthalmologic findings in acquired immune 
deficiency syndrome (AIDS). Arch Ophthalmol Feb 1984; 102:201-206. 
18. Newsome DA, et al: Microvascular aspects of acquired immune 
deficiency syndrome retinopathy. Am J Ophthalmol Nov 1984; 
98(5):590-601. 
19. Holland GN, et al: Retinal cotton-wool patches in acquired 
immunodeficiency syndrome. N Eng I J Med 1982; 307(2) :1704. 
20. Mcleod D, et al: The role of axoplasmic transport in the pathogenesis 
of cotton-wool spots. Br J Ophthalmol 1977; 61 (3) :177-191. 
21. Kwok S, et al: Retinal cotton-wool spots in a patient with 
Pneumocystis carinii infection. N Eng I J Med 1982; 307(2) :184-185. 
22. Holland GN, et al: Ocular disorders associated with a new severe 
acquired cellular immunodeficiency syndrome. Am J Ophthalmol Apr 
1982; 93(4):393-402. 
23. Freeman WR, et al: A prospective study of the ophthalmologic findings 
in the acquired immune deficiency syndrome. Am J Ophthalmol Feb 
1984; 97(2) :133-142. 
11 
24. Pepose JS, et al: An analysis of retinal cotton-wool spots and 
cytomegalovirus retinitis in the acquired immunodeficiency 
syndrome. Am J Ophthalmol Jan 1983; 95(1) :118-120. 
25. Eqbert PR, et al: Cytomegalovirus retinitis in immunosuppressed 
hosts: II: Ocular manifestations. Ann lnt Med 1980; 93:664-670. 
26. Palestine AG, et al: Treatment of cytomegalovirus retinitis with 
dihydroxy propoxymethyl guanine. Am J Ophthalmol Jan 1986; 
101(1):95-101. 
27. Neuwirth J, et al: Cytomegalovirus retinitis in a young homosexual 
male with acquired immunodeficiency syndrome. Ophthalmol Jul 1982; 
89{7) :805-808. 
28. Buckman G, et al: Retinal manifestations of acquired 
immunodeficiency syndrome (AIDS). Report of a case. Ann Ophthalmol 
Dec 1984; 16(12):1136-1138. 
29. Duane TO, et al: White centered hemorrhages: their significance. 
Ophthalmol Jan 1980; 87(1 ):66-69. 
30. Kestelyn P, et al: A prospective study of the ophthalmoscopic findings 
in the acquired immune deficiency syndrome in Africa. Am J 
Ophthalmol Aug 1985; 1 00(2):230-238. 
31. Weiss A, et al: Toxoplasmic retinochoroiditis as an 
manifestation of the acquired immune deficiency syndrome. 
Ophthalmol Feb 1986: 101 (2):248-249. 
initial 
Am J 
32. Parke OW, Font RL: Diffuse toxoplasmic retinochoroiditis in a patient 
with AIDS. Arch Ophthalmol Apr 1986; 1 04(4) :571-575. 
33. Croxatto JR, et al: 
immune deficiency 
1 02( 4) :659-660. 
Nonreactive tuberculosis in a patient with acquired 
syndrome. Am J Ophthalmol Nov 1986; 
12 
